<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(1)</volume><submitter>Kherabi Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Staphylococci and streptococci are the most frequent pathogens isolated from prosthetic joint infections (PJIs). The aim of this study was to analyze the outcome of streptococcal and methicillin-susceptible Staphylococcus aureus (MSSA) PJIs.&lt;h4>Methods&lt;/h4>All monomicrobial streptococcal and MSSA PJIs managed in a French Referral Center (2010-2017) were sampled from the prospective PJIs cohort study. The primary outcome of interest was the cumulative reinfection-free survival at a 2-year follow-up.&lt;h4>Results&lt;/h4>Two hundred and nine patients with 91 streptococcal and 132 staphylococcal infections were analyzed. Patients with streptococcal PJI were older, and infection was more frequently hematogenous. Reinfection-free survival rates at 2-years after all treatment strate</pubmed_abstract><journal>BMC infectious diseases</journal><pagination>555</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9206280</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?</pubmed_title><pmcid>PMC9206280</pmcid><pubmed_authors>Meyssonnier V</pubmed_authors><pubmed_authors>Zeller V</pubmed_authors><pubmed_authors>Marmor S</pubmed_authors><pubmed_authors>Heym B</pubmed_authors><pubmed_authors>Lidove O</pubmed_authors><pubmed_authors>Kerroumi Y</pubmed_authors><pubmed_authors>Kherabi Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Streptococcal and Staphylococcus aureus prosthetic joint infections: are they really different?</name><description>&lt;h4>Background&lt;/h4>Staphylococci and streptococci are the most frequent pathogens isolated from prosthetic joint infections (PJIs). The aim of this study was to analyze the outcome of streptococcal and methicillin-susceptible Staphylococcus aureus (MSSA) PJIs.&lt;h4>Methods&lt;/h4>All monomicrobial streptococcal and MSSA PJIs managed in a French Referral Center (2010-2017) were sampled from the prospective PJIs cohort study. The primary outcome of interest was the cumulative reinfection-free survival at a 2-year follow-up.&lt;h4>Results&lt;/h4>Two hundred and nine patients with 91 streptococcal and 132 staphylococcal infections were analyzed. Patients with streptococcal PJI were older, and infection was more frequently hematogenous. Reinfection-free survival rates at 2-years after all treatment strate</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-05T16:14:35.148Z</modification><creation>2025-04-05T16:14:35.148Z</creation></dates><accession>S-EPMC9206280</accession><cross_references><pubmed>35715754</pubmed><doi>10.1186/s12879-022-07532-x</doi></cross_references></HashMap>